(Q37538386)

20 August 2017

1 reference

title

Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination (English)

1 reference

20 August 2017

1 reference

Robert W Johnson

1

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Aging Clinical and Experimental Research

20 August 2017

published in

1 reference

20 August 2017

volume

21

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

236-243

1 reference

The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Varicella in Americans from NHANES III: implications for control through routine immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The effect of vaccination on the epidemiology of varicella zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Risk factors for postherpetic neuralgia in patients with herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Herpes zoster itch: preliminary epidemiologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The burden of Herpes Zoster: a prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Aging, immunity, and the varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Recommendations for the Management of Herpes Zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Herpes zoster and the prevention of postherpetic neuralgia: beyond antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324909

21 January 2018

Identifiers

DOI

10.1007/BF03324909

1 reference

20 August 2017

1 reference